Hyderabad-based Genomelabs Bio, a nutraceuticals company, which makes innovative products as well as markets products of global nutraceutical companies in India, is setting up two new facilities, one each in Hyderabad and Visakhapatnam. The company plans to invest Rs 200 crore in the next one year. It is also planning to tap export markets across South Asia.
Of the total investment, the company will invest Rs 100 crore in setting up the manufacturing facility in Hyderabad, Rs 50 crore facility in Visakhapatnam and another Rs 50 crore will be invested in research and development and marketing of products. Hyderabad facility alone could create a turnover of Rs 1,000 crore, once fully operational.